The use of transjugular intrahepatic portosystemic shunt should be cautious in patients without cirrhosis with obliterative portal vein thrombosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|64|4|1374-1375

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.64, Iss.4, 2016-10, pp. : 1374-1375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Intrahepatic shunt & refractory ascites

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 389-395

John Wiley & Sons Inc

Access to resources Recommend Favorite

Etiology of cirrhosis predicts deterioration of “brain reserve” after hepatic encephalopathy or transjugular intrahepatic portosystemic shunt

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 9, 2015-09 ,pp. : 1115-1116

John Wiley & Sons Inc

Access to resources Recommend Favorite

Modification of splenic stiffness on acoustic radiation force impulse parallels the variation of portal pressure induced by transjugular intrahepatic portosystemic shunt

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 33, Iss. 3, 2018-03 ,pp. : 704-709

John Wiley & Sons Inc

Access to resources Recommend Favorite

Increased risk of portal vein thrombosis in patients with cirrhosis due to nonalcoholic steatohepatitis

By  

LIVER TRANSPLANTATION, Vol. 21, Iss. 8, 2015-08 ,pp. : 1016-1021

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety and efficacy of transarterial chemoembolization in patients with transjugular intrahepatic portosystemic shunts

By  

HPB, Vol. 17, Iss. 8, 2015-08 ,pp. : 707-712

John Wiley & Sons Inc

Access to resources Recommend Favorite